Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Molecular diagnostics in urologic malignancies: a work in progress.

Netto GJ.

Arch Pathol Lab Med. 2011 May;135(5):610-21. doi: 10.1043/2010-0727-RAIR.1. Review.

PMID:
21526959
[PubMed - indexed for MEDLINE]
2.

Theranostic and prognostic biomarkers: genomic applications in urological malignancies.

Netto GJ, Epstein JI.

Pathology. 2010 Jun;42(4):384-94. doi: 10.3109/00313021003779145. Review.

PMID:
20438413
[PubMed - indexed for MEDLINE]
3.

Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Netto GJ, Cheng L.

Arch Pathol Lab Med. 2012 Apr;136(4):372-90. doi: 10.5858/arpa.2011-0471-RA. Review.

PMID:
22458900
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].

Müller M, Goessl C, Krause H, Miller K.

Urologe A. 2003 May;42(5):660-8. Epub 2003 Apr 4. Review. German.

PMID:
12750801
[PubMed - indexed for MEDLINE]
5.

Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?

Netto GJ.

Adv Anat Pathol. 2013 May;20(3):175-203. doi: 10.1097/PAP.0b013e3182863f80. Review.

PMID:
23574774
[PubMed - indexed for MEDLINE]
6.

Epidemiology and molecular biology of early prostatic neoplasia.

Sakr WA, Ward C, Grignon DJ, Haas GP.

Mol Urol. 2000 Fall;4(3):109-13;discussion 115. Review.

PMID:
11062364
[PubMed - indexed for MEDLINE]
7.

Clinical implications of current developments in genitourinary pathology.

Zhou AG, Owens CL, Cosar EF, Jiang Z.

Arch Pathol Lab Med. 2013 Jul;137(7):887-93. doi: 10.5858/arpa.2012-0210-RA. Review.

PMID:
23808460
[PubMed - indexed for MEDLINE]
8.

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.

Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr, van de Rijn M, Brooks JD.

Am J Surg Pathol. 2007 May;31(5):673-80.

PMID:
17460449
[PubMed - indexed for MEDLINE]
9.

Diagnosis and prognosis of renal-cell tumors: a molecular approach.

Wilhelm M, Krause U, Kovacs G.

World J Urol. 1995;13(3):143-8. Review.

PMID:
7550384
[PubMed - indexed for MEDLINE]
10.

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

Netto GJ.

Nat Rev Urol. 2011 Dec 13;9(1):41-51. doi: 10.1038/nrurol.2011.193. Review.

PMID:
22158597
[PubMed - indexed for MEDLINE]
11.

Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.

Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D.

Clin Cancer Res. 2005 Jul 15;11(14):5146-52.

PMID:
16033829
[PubMed - indexed for MEDLINE]
Free Article
12.

Molecular diagnostics of lung carcinomas.

Dacic S.

Arch Pathol Lab Med. 2011 May;135(5):622-9. doi: 10.1043/2010-0625-RAIR.1. Review.

PMID:
21526960
[PubMed - indexed for MEDLINE]
13.

Minimal criteria for the diagnosis of prostate cancer on needle biopsy.

Bostwick DG, Iczkowski KA.

Ann Diagn Pathol. 1997 Dec;1(2):104-29. Review.

PMID:
9869832
[PubMed - indexed for MEDLINE]
14.

Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.

Cheng L, Williamson SR, Zhang S, Maclennan GT, Montironi R, Lopez-Beltran A.

Expert Rev Anticancer Ther. 2010 Jun;10(6):843-64. doi: 10.1586/era.10.72. Review.

PMID:
20553210
[PubMed - indexed for MEDLINE]
15.

[Value of biomarkers in urology].

Goebell PJ, Keck B, Wach S, Wullich B.

Urologe A. 2010 Apr;49(4):547-59. doi: 10.1007/s00120-010-2286-8. Review. German.

PMID:
20376654
[PubMed - indexed for MEDLINE]
16.

Future prognostic factors for renal cell carcinoma: Workgroup No. 5. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Swanson DA, Rothenberg HJ, Boynton AL, Consigliere D, Halling KC, Oda H, Smith D.

Cancer. 1997 Sep 1;80(5):997-8. No abstract available.

PMID:
9307207
[PubMed - indexed for MEDLINE]
17.

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.

Bettendorf O, Schmidt H, Staebler A, Grobholz R, Heinecke A, Boecker W, Hertle L, Semjonow A.

Genes Chromosomes Cancer. 2008 Jul;47(7):565-72. doi: 10.1002/gcc.20560.

PMID:
18383208
[PubMed - indexed for MEDLINE]
18.

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.

PMID:
18483744
[PubMed - indexed for MEDLINE]
19.
20.

Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.

Teixeira MR, Ribeiro FR, Eknaes M, Waehre H, Stenwig AE, Giercksky KE, Heim S, Lothe RA.

Cancer. 2004 Oct 15;101(8):1786-93.

PMID:
15386312
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk